Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death

Study identifier:D961FN00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death - Nested case control analyses in a cohort of patients with acute serious coronary heart disease

Medical condition

Nonfatal Myocardial infarction

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

42542

Study type

Observational

Age

50 Years - 84 Years

Date

Study Start Date: 01 Jul 2011

Primary Completion Date: 01 Dec 2011

Study Completion Date: 01 Dec 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Madrid, Spain

Location

Research Site

Molndal, Sweden

Arms	Assigned Interventions
Cases Cases with nonfatal MI or coronary death	-
Controls Age, sex, and calendar-year matched controls sampled from the original study cohort to be a round number of at least four times the number of cases	-

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=701&filename=CSR-D961FN00007.pdf
Download
CSR-D961FN00007.pdf
Download
D961FN00007 Clinical Study Protocol
Download
Trial Results Summaries
Available here

Contacts

Contact

Saga Johansson

+46 31 7761526

saga.johansson@astrazeneca.com

Investigators

Principal Investigator

Luis A Garcia Rodriguez

CEIFE (Centro Español de Investigación Farmacoepidemiológica)

Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=701&filename=CSR-D961FN00007.pdf

CSR-D961FN00007.pdf

D961FN00007 Clinical Study Protocol

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator